I agree that this site is using cookies. You can find further informations here.
X
García-Calduch, Olga
22  results:
Search for persons X
?
1

Feasibility and outcomes after dose reduction of immunochem..:

Ribera, Josep-Maria ; Morgades, Mireia ; Garcia-Calduch, Olga...
Haematologica.  109 (2023)  2 - p. 543-552 , 2023
Link: https://doi.org/10.3324/..
 
?
2

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMU..:

Maria Ribera, Josep ; Morgades, Mireia ; García-Calduch, Olga...
HemaSphere.  7 (2023)  S3 - p. e813564b , 2023
Link: https://doi.org/10.1097/..
 
?
3

Ponatinib, chemotherapy, and transplant in adults with Phil..:

Ribera, Josep-Maria ; García-Calduch, Olga ; Ribera, Jordi...
Blood Advances.  6 (2022)  18 - p. 5395-5402 , 2022
Link: https://doi.org/10.1182/..
 
?
4

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMU..:

Maria Ribera, Josep ; Morgades, Mireia ; García-Calduch, Olga...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431106/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Ponatinib, chemotherapy, and transplant in adults with Phil..:

Ribera, Jose-Maria ; García-Calduch, Olga ; Ribera, Jordi...
Ministerio de Economía y Competitividad PI14/01971.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
6

Ponatinib, chemotherapy, and transplant in adults with Phil..:

Ribera, Josep-Maria ; García-Calduch, Olga ; Ribera, Jordi...
http://hdl.handle.net/10668/20253.  , 2022
Link: http://hdl.handle.net/10..
 
?
7

Ponatinib, chemotherapy, and transplant in adults with Phil..:

Ribera, Josep-Maria ; García-Calduch, Olga ; Ribera, Jordi...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2022
Link: http://hdl.handle.net/10..
 
?
8

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMU..:

Josep Maria Ribera ; Mireia Morgades ; Olga García-Calduch...
http://journals.lww.com/10.1097/01.HS9.0000971484.81356.4b.  , 2023
Link: https://doi.org/10.1097/..
 
?
9

Host–pathogen interactions uponCandida aurisinfection: fung..:

Garcia-Bustos, Victor ; Pemán, Javier ; Ruiz-Gaitán, Alba...
Emerging Microbes & Infections.  11 (2021)  1 - p. 136-146 , 2021
Link: https://doi.org/10.1080/..
 
?
10

Successful cryopreservation in biodegradable containers of ..:

França, T.S. ; González-López, W.A. ; Sanchez, M.P....
Theriogenology.  216 (2024)  - p. 53-61 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Corrigendum: Revising the Impact and Prospects of Activity ..:

Calduch-Giner, Josep ; Holhorea, Paul George ; Ferrer, Miguel Ángel...
Frontiers in Marine Science.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
12

Revising the Impact and Prospects of Activity and Ventilati..:

Calduch-Giner, Josep ; Holhorea, Paul George ; Ferrer, Miguel Ángel...
Frontiers in Marine Science.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
13

Diet and Exercise Modulate GH-IGFs Axis, Proteolytic Marker..:

Perelló-Amorós, Miquel ; García-Pérez, Isabel ; Sánchez-Moya, Albert...
Animals.  11 (2021)  8 - p. 2182 , 2021
Link: https://doi.org/10.3390/..
 
?
14

On the advice to perform a new MRI within 2 weeks prior to ..:

Macià i Garau, M. ; Pons Escoda, A. ; García Expósito, N..
Radiotherapy and Oncology.  190 (2024)  - p. 109964 , 2024
Link: https://doi.org/10.1016/..
 
?
15

P21.06.A TIME IN ONCOLOGY. GLIOBLASTOMA REAL-WORLD DATA:

Macià i Garau, M ; Lucas Calduch, A ; García Expósito, N
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii132-ii132 , 2023
Link: https://doi.org/10.1093/..
 
1-15